Información del artículo
El Texto completo está disponible en PDF
References
[1.]
M.R. Holdiness.
Contact dermatitis to topical drugs for glaucoma.
Am J Contact Dermatitis, 12 (2001), pp. 217-219
[2.]
J.F. Silvestre, L. Carnero, R. Ramón, M.P. Albares, R. Botella.
Allergic contact dermatitis from apraclonidine in eyedrops.
Contact Dermatitis, 45 (2001), pp. 251
[3.]
R.L. Gross, A. Pinyero, S. Orengo-Nania.
Clinical experience with apraclonidine 0.5%.
J Glaucoma, 6 (1997), pp. 298-302
[4.]
P. Butler, M. Mannschreck, S. Lin, I. Hwang, J. Alvarado.
Clinical experience with the long-term use of 1% apraclonidine. Incidence of allergic reactions.
Arch Ophthalmol, 113 (1995), pp. 293-296
[5.]
M. Armisen, C. Vidal, R. Quitans, A. Suárez, M. Castroviejo.
Allergic contact dermatitis from apraclonidine.
Contact Dermatitis, 39 (1997), pp. 193
[6.]
D.H. Shin, B.K. Glover, S.C. Cha, Y.Y. Kim, C. Kim, K.D. Nguyen.
Long-term Brimonidine therapy in glaucoma patients with apraclonidine allergy.
Am J Ophtalmol, 127 (1999), pp. 511-515
Copyright © 2009. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
